Announcement on Waiving the Acquisition Opportunity of PLBIO
Filed with SSE · · 6 pages · Chinese
Beijing Tiantan Biological Products Corporation Limited on 6ix
Earlier from Beijing Tiantan Biological Products
- Announcement on Subsidiary Obtaining Notice of Approval for Drug Supplementary Application
- Announcement on Resolutions of the 22nd Meeting of the 9th Board of Directors
- Announcement on Subsidiary Obtaining Notice of GMP Compliance Inspection
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Resolution of the 2024 Annual General Meeting
Later from Beijing Tiantan Biological Products
- Brief Announcement on Semi-annual Earnings for 2025
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- 2025 Semi-annual Report
- Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
- Announcement on Convening the 2025 Semi-annual Performance Briefing
Follow Beijing Tiantan Biological Products into a list and get an email when it puts out news.
Follow Beijing Tiantan Biological Products